FindTrial
Sign In

The effect of metabolic syndrome ( MetS ) on the incidence of adolescent ovulatory dysfunctional uterine bleeding ( AUB-O ) and the follow-up outcome after sex hormone therapy.

The effect of metabolic syndrome ( MetS ) on the incidence of adolescent ovulatory dysfunctional uterine bleeding ( AUB-O ) and the follow-up outcome after sex hormone therapy.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091369
Enrollment
Unknown
Registered
2024-10-28
Start date
2024-11-01
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovulatory dysfunctional uterine bleeding ( AUB-O )

Interventions

Case group ( MetS group ):Dydrogesterone
Observation group ( cross-sectional survey ):None
Control group:Dydrogesterone

Sponsors

The Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
12 Years to 19 Years

Inclusion criteria

Inclusion criteria: 1 ) Girls aged 12-19 years, one year after menarche ; 2 ) is in the primary or high school education stage.

Exclusion criteria

Exclusion criteria: 1 ) liver and kidney disease, liver and kidney dysfunction beyond the upper limit of the normal value of 2 times ; 2 ) suffering from immune system diseases ; 3 ) During the dialysis treatment of diabetes ; 4 ) Type 1 diabetes ; 5 ) Blood system diseases, genital organic diseases ; 6 ) Thyroid dysfunction.

Design outcomes

Primary

MeasureTime frame
menstrual pattern;metabolic indexes;—

Countries

Chnia

Contacts

Public ContactYuan Yuan

The Affiliated Hospital of Southwest Medical University

yuanyuan413713@163.com+86 173 8000 1606

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026